"tyrosine kinase" trang 11 - tải miễn phí từ tailieunhanh
Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing

Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing
12    31    1
Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients

Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients
6    56    1
Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment

Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment
12    34    1
Modification of topoisomerases in mammospheres derived from breast cancer cell line: Clinical implications for combined treatments with tyrosine kinase inhibitors

Modification of topoisomerases in mammospheres derived from breast cancer cell line: Clinical implications for combined treatments with tyrosine kinase inhibitors
17    33    1
Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions

Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions
15    55    1
Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration

Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration
11    53    1
Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer

Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer
8    56    1
Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer

Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer
11    51    1
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma

Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma
8    45    1
Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis

Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis
13    47    1
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation
9    42    1
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer
10    36    1
Early onset recall pneumonitis during targeted therapy with sunitinib

Early onset recall pneumonitis during targeted therapy with sunitinib
4    28    1
SCMBYK: Prediction and characterization of bacterial tyrosine-kinases based on propensity scores of dipeptides

SCMBYK: Prediction and characterization of bacterial tyrosine-kinases based on propensity scores of dipeptides
15    50    1
EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib

EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib
10    72    1
Kháng thuốc ức chế tyrosine kinase thế hệ thứ nhất ở bệnh nhân ung thư phổi không tế bào nhỏ

Kháng thuốc ức chế tyrosine kinase thế hệ thứ nhất ở bệnh nhân ung thư phổi không tế bào nhỏ
9    44    1
Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: A prospective cohort study

Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: A prospective cohort study
9    45    1
Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib
9    42    1
EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function

EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function
10    37    1
Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents
5    41    1